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Abstract
Objective: Pancreas-related complications are some of the most serious ones in abdominal
surgery. The goal of this study was to develop and validate novel near-infrared (NIR) fluorophores
that would enable real-time pancreas imaging to avoid the intraoperative pancreatic injury.
Design: After initial screening of a large NIR fluorophore library, the performance of 3 selected
pancreas-targeted 700 nm NIR fluorophores, T700-H, T700-F, and MB, were quantified in mice,
rats, and pigs. Dose ranging using 25 and 100 nmol, and 2.5 µmol of T700-F, and its imaging kinetics
over a 4 h period were tested in each species. Three different 800 nm NIR fluorophores were
employed for dual-channel FLARE™ imaging in pigs: 2 μmol of ZW800-1 for vessels and kidney, 1
μmol of ZW800-3C for lymph nodes, and 2 μmol of ESNF31 for adrenal glands.
Results: T700-F demonstrated the highest signal to background ratio (SBR), with peak SBR at 4 h
postinjection in mice. In pigs, T700-F produced an SBR ≥ 2 against muscle, spleen, and lymph nodes
for up to 8 h after a single intravenous injection. The combination of T700-F with each 800 nm NIR
fluorophore provided simultaneous dual-channel intraoperative imaging of pancreas with surrounding organs in real time.
Conclusion: Pancreas-targeted NIR fluorophores combined with the FLARE dual-channel imaging system enable the real-time intraoperative pancreas imaging which helps surgeons perform
safer and more curative abdominal surgeries.
Key words: Pancreas-related complications, Postoperative pancreatic fistula, Intraoperative pancreatic injury, Image-guided surgery, Near-Infrared fluorescence.

Introduction
Pancreas-related complications in abdominal
surgery are serious and sometimes fatal. Unrecognized intraoperative pancreatic injury results in many
pancreas-related complications, such as postoperative

pancreatic fistulae, peripancreatic abscesses, and
pancreatitis [1,2]. These can progress to more serious
complications such as intra-abdominal hemorrhage
and septic shock, which result in longer hospital stays
http://www.thno.org
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and higher medical costs [3]. The incidence of pancreas-related complications after gastrectomy with
radical lymphadenectomy, which is the standard
procedure in advanced gastric cancers, ranges from
5.8 to 49.7% [3-8]. Even performing laparoscopic gastrectomy, which offers a magnified view of the surgical field, reported complication rates range from 4.3
to 7.2% [1,2]. In addition to other gastrointestinal
surgeries such as colectomy and splenectomy [9],
urological surgeries including nephrectomy and
adrenalectomy also have a high risk factor of pancreas-related complications [10].
Intraoperative pancreatic injuries are typically
caused by the proximity of the pancreas to surrounding organs and the difficulty in distinguishing
the edge of the pancreas from surrounding fat tissue,
especially in obese patients. Real-time, high sensitivity identification of the pancreas intraoperatively
could help avoid such injury. Previously we reported
that near-infrared (NIR) fluorescent light could be
used to identify both the pancreas and insulinoma by
employing the clinically available NIR fluorophore
methylene blue (MB) [11]. Although MB provided
contrast between the pancreas and surrounding organs, it is not an ideal NIR contrast agent because of
low signal intensity, nonspecific uptake, and short
retention time in the pancreas.
Recently, we developed a library of NIR fluorophores targeted to various tissues and organs including thyroid and parathyroid [12], lymph nodes [13],
nerves [14], adrenal glands [15], and bone [16] with
high signal in the target and relatively low background after a single intravenous injection. Furthermore, screening the in vivo performance of our over
300 novel compounds, we found T700-F and T700-H
could target the pancreas specifically. Combined with
our FLARE intraoperative imaging system, which
provides simultaneous dual-channel NIR fluorescence imaging along with color video, various surgeries can now be performed under real-time image
guidance [17]. In this study, we hypothesized that the
same approach could be used for pancreas imaging,
and focused our experiments on novel agents that
could outperform MB.

Materials and Methods
NIR Fluorescent Contrast Agents: Methylene
blue (MB; USP 1%, 10 mg/mL) was purchased from
Taylor Pharmaceuticals (Decatur, IL). T700-H and
T700-F were synthesized as described in our previous
reports [12,18-20], and served as pancreas targeting
700 nm emitting NIR fluorophores. Three different
800 nm NIR fluorophores including ZW800-1,
ZW800-3C, and ESNF31, were also used for the dual
channel imaging of surrounding tissue: ZW800-1 for

2
NIR angiography and kidney imaging [21];
ZW800-3C for PLN imaging [13], and ESNF31 for adrenal glands [15]. MB was used as purchased without
further treatment (31.3 mM), and all other NIR
fluorophores were dissolved in dimethyl sulfoxide
(DMSO) as a 10 mM stock solution.
Optical Property Measurements: Optical properties of NIR fluorescent contrast agents were measured in 100% fetal bovine serum (FBS) supplemented
with 50 mM HEPES, pH 7.4. The quantum yield (QY)
of 700 nm NIR fluorophores was measured using
Oxazine 725 (Sigma-Aldrich) in ethylene glycol (QY =
19%) was used as a calibration standard under conditions of matched absorbance at 655 nm [22], while
indocyanine green (ICG) in DMSO (QY = 13%) was
used for the QY of 800 nm NIR fluorophores with a
matched absorbance at 770 nm [23]. For in vitro optical
property measurements, online fiberoptic HR2000
absorbance (200-1100 nm) and USB2000FL fluorescence (350-1000 nm) spectrometers (Ocean Optics,
Dunedin, FL) were used. NIR excitation was provided
by 5 mW of 655 nm red laser pointer (Opcom Inc.,
Xiamen, China) and 8 mW of 765 nm NIR laser diode
light source (Electro Optical Components, Santa Rosa,
CA) coupled through a 300 µm core diameter, NA 0.22
fiber (Fiberguide Industries, Stirling, NJ). In silico
calculations of the distribution coefficient (logD at pH
7.4) and 3D minimized structures were calculated
using Marvin and JChem calculator plugins (ChemAxon, Budapest, Hungary).
Animal Models: Animals were housed in an
Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC)-certified facility
and were studied under the supervision of Beth Israel
Deaconess Medical Center’s Institutional Animal Care
and Use Committee (IACUC) in accordance with approved institutional protocols #101-2011 for rodents
and #034-2013 for pigs. Male CD-1 mice (n = 42) averaging 21 g and male Sprague-Dawley rats (n = 6)
averaging 262 g (Charles River Laboratories, Wilmington, MA) were anaesthetized with 100 mg/kg
ketamine and 10 mg/kg xylazine intraperitoneally
(Webster Veterinary, Fort Devens, MA) and a midline
laparotomy was performed to expose the viscera.
Female Yorkshire pigs (n = 12) averaging 35.5 kg
(E.M. Parsons and Sons, Hadley, MA) were induced
with 4.4 mg/kg intramuscular Telazol (Fort Dodge
Laboratories, Fort Dodge, IA) and intubated; anesthesia was maintained with 2% isoflurane (Baxter
Healthcare, Deerfield, IL). Following anesthesia, a
14-G central venous catheter was inserted into the
external jugular vein, and saline was administered as
needed. A midline laparotomy and a left trans-rectus
incision were performed for satisfactory intraoperative imaging. Electrocardiogram, heart rate, pulse
http://www.thno.org
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oximetry, and body temperature were monitored
during the experiment.
NIR Fluorescence Imaging System: The dual-NIR channel FLARE imaging system has been described in detail previously [17,24]. In this study, 670
nm excitation and 760 nm excitation fluence rates
used were 4.0 and 11.0 mW/cm2, respectively, with
white light (400 to 650 nm) at 40,000 lx. Color image
and 2 independent channels (700 nm and 800 nm) of
NIR fluorescence images were acquired simultaneously with custom software at rates up to 15 Hz over a
15-cm diameter field of view (FOV). In the color-NIR
merged images, 700 nm NIR fluorescence and 800 nm
fluorescence were pseudo-colored red and lime green,
respectively. The imaging system was positioned at a
distance of 18 inches from the surgical field. Camera
exposure time and normalization were held constant
for each experiment.
Intraoperative Pancreas Imaging in Mice, Rats,
and Pigs: For initial in vivo screening, 25 nmol of
T700-H and T700-F were injected intravenously into
CD-1 mice 4 h prior to imaging (n = 3 per each fluorophore). As a control, 120 nmol (1.5 mg/kg) of MB
was injected 15 min prior to imaging (n = 3) [11]. In
the dose optimization study, we injected 5 different
doses of T700-F (0, 10, 25, 50, and 100 nmol) and images were taken at 4 h post-injection (n = 3 per each
dose). For the kinetics study, we injected 25 nmol of
T700-F intravenously and observed the fluorescent
signal of pancreas at 6 different time points (0, 1, 2, 4,
8, and 24 h) (n = 3 per each time point). For rat studies,
1.2 µmol of MB (1.5 mg/kg) and 100 nmol of T700-F
were injected intravenously 15 min and 4 h prior to
imaging, respectively (n = 3 each NIR fluorophore).
All NIR fluorophores except for MB were diluted into
5% dextrose in water (D5W) before injection, and 100
µL was injected into mice and 500 µL was injected into
rats, respectively.
For large animal swine studies, 164 µmol (1.5
mg/kg) of MB and 2.5 µmol of T700-F were injected
intravenously. We observed the fluorescent signals of
viscera for 1 h post-injection, calculated a signal-to-background ratio (SBR) at 6 different time
points (0, 3, 5, 15, 30, and 60 min), and compared the
performance (n = 3 per each fluorophore). Next, we
performed kinetics study using 2.5 µmol of T700F,
and images were recorded at 11 different time points
(0, 15, 30, 60, 90, 120, 180, 240, 300, 360, and 480) (n =
3). Finally, we tested dual-channel imaging of pancreas with surrounding vital tissues and organs including arteries, kidneys, pan lymph nodes (PLNs),
and adrenal glands: 2 µmol of ZW800-1 for NIR arteriography and kidney imaging, 1 µmol of ZW800-3C
for PLN imaging, and 2 µmol of ESNF31 for adrenal
gland imaging (n = 1 for each study). The NIR angi-
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ography was recorded immediately after a single intravenous injection of ZW800-1 and kidneys were
imaged 2 h post-injection. The PLN imaging was
performed 4 h post-injection, while adrenal glands
were imaged at 30 min post-injection. These imaging
times were chosen based on prior optimization
[13,15,25]. Each NIR agent was diluted into 10 mL of
D5W prior to injection.
NIR Fluorescence Microscopy: For histological
evaluations, pancreatic tissues were resected from rats
after scheduled imaging using MB and T700-F, embedded in Tissue-Tek OCT compound (Fisher Scientific, Pittsburgh, PA), and flash frozen in liquid nitrogen. Tissue was cryosectioned at 10 µm intervals
and observed using a NIR fluorescence microscope.
Consecutive sections were stained with hematoxylin
and eosin (H&E). NIR fluorescence microscopy was
performed on a 4 filter-set Nikon Eclipse TE300
epifluorescence microscope to confirm the fluorescence of the pancreas as previously described [26,27].
The microscope was equipped with a 100 W mercury
light source, NIR-compatible optics, and a
NIR-compatible 4X, 10X, 20X, and 40X Plan Fluor objective lens (Nikon, Melville, NY). Custom filter sets
(Chroma Technology Corporation, Brattleboro, VT)
composed of a 650 ± 22 nm excitation filter and a 710 ±
25 nm emission filter were used to detect the pancreas
fluorescence signal. Images were acquired on an Orca-AG (Hamamatsu, Bridgewater, NJ) and QImaging
12-bit camera for color imaging (Surrey, BC, Canada).
Image acquisition and analysis was performed using
iVision software (BioVision Technologies, Exton, PA).
Quantitation and Statistical Analysis: The fluorescent intensity (FI) of a region of interest (ROI)
over the pancreas, rectus abdominis muscle, liver,
spleen, duodenum, lymph nodes, and kidneys were
quantified using custom FLARE software. The performance metric for this study was SBR. SBR = FI of
ROI / background (BG) intensity. The rectus abdominis muscles, liver, spleen, duodenum, lymph nodes,
and kidneys were used as BG compared to the signal
in the pancreas to yield pancreas-to-muscle ratio
(Pa/Mu), pancreas-to-liver ratio (Pa/Li), pancreas-to-spleen ratio (Pa/Sp), pancreas-to-duodenum
ratio (Pa/Du), pancreas-to-lymph node ratio
(Pa/LN), and pancreas-to-kidney ratio (Pa/Ki). At
least 3 animals were analyzed for SBR at each time or
dose point. Results were presented as mean ± standard deviation (SD). The statistical analysis was performed using the Unpaired T test between two groups
and a one-way ANOVA followed by Tukey’s multiple
comparisons test between multiple groups. A P value
of less than 0.05 was considered significant: *P < 0.05,
**P < 0.01, and ***P < 0.001.

http://www.thno.org
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Results
Optical properties of NIR fluorescent contrast
agents. The chemical structure, absorbance, and fluorescence spectra for MB, T700-H, T700-F, ZW800-1,
ZW800-3C, and ESNF31 are shown in Figure 1. Additionally, Table 1 details the optical properties of each
NIR fluorophore in 100% serum. T700 fluorophores
have 2-3 fold higher extinction coefficient and more
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than 3-fold higher QY compared to MB, which resulted in a total of 8-fold higher molecular brightness
(Table 1). To summarize, MB, T700-H, and T700-F
exhibited optical properties compatible with NIR fluorescence channel #1 (700 nm) of the FLARE imaging
system, while ZW800-1, ZW800-3C, and ESNF31 were
imaged using NIR fluorescence channel #2 (800 nm),
which permits simultaneous, real-time, dual-channel
intraoperative imaging.

Figure 1. Chemical Structure and Optical Properties of NIR Fluorophores. Chemical structure, molecular weight (MW), and logD at pH 7.4 were depicted using MarvinSketch
(ChemAxon). Absorbance (Abs) and fluorescence (FL) emission spectra were measured in 100% fetal bovine serum at pH 7.4. a) 700 nm NIR Fluorophores. b) 800 nm NIR
Fluorophores.

http://www.thno.org
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Table 1. Optical properties of NIR fluorophores in 100% serum supplemented with 50 mM HEPES (pH 7.4).
Optical Property
FLARE Imaging Channel
Extinction Coefficient (M-1cm-1)
Absorbance Maximum (nm)
Emission Maximum (nm)
Quantum Yield (%)
Molecular Brightness (M-1cm-1)

MB
T700-H
700 nm NIR (Channel #1)
49,500
147,000
665
648
688
670
9.6
30.4
4,752
44,688

T700-F
123,000
651
665
29.9
36,777

ZW800-1
ZW800-3C
800 nm NIR (Channel #2)
249,000
309,000
772
774
788
789
15.1
16.1
37,599
49,749

ESNF31
135,000
803
814
10.8
14,580

In silico calculations of logD at pH 7.4 and total polar surface area were calculated using Marvin and JChem calculator plugins (ChemAxon, Budapest, Hungary).

Initial in vivo screening in mice. Our NIR
fluorophore library consists of over 300 novel compounds. Initial screening in mice revealed 2 pentamethine indocyanine fluorophores, T700-H and
T700-F, with unusually high uptake in pancreas
(Supplementary Material: Figure S1). T700-F showed
a stronger pancreas signal and higher contrast to
surrounding organs, such as duodenum, spleen, and
liver. Both, however, also had strong kidney signal
due to renal elimination. We then compared these two
NIR fluorophores to clinically available MB in mice
and re-measured SBR. As shown Figure 2A, T700-F
showed the highest uptake in pancreas compared to
others, and a significant improvement in SBR was
found when compared with MB, which was injected
at a 4-fold higher dose and exhibited a 10-fold shorter
retention time [11]. Because T700-F demonstrated the
highest SBR, we explored its dose optimization and
kinetics, and expanded the study to 2 additional species, rats and pigs.
Kinetics and dose optimization of T700-F in
mice. To optimize the best imaging time for pancreas
(Pa), we injected 25 nmol of T700-F intravenously into
CD-1 mice and measured the SBR of pancreas and
surrounding tissues over the course of 24 h. As shown
in Figure 2B, the highest SBR relative to liver (Li),
spleen (Sp), and duodenum (Du), was achieved at 4 h
post-injection although the background signal decreased continuously over time, the fluorescence signal of pancreas also diminished significantly after 4 h
(Figure 2D). Therefore, dose optimization was performed at 4 h post-injection. Of note, no adverse reactions were encountered over the 24 h observation period.
For dose-optimization, we injected 5 different
doses of T700-F (0, 10, 25, 50, and 100 nmol) into CD-1
mice, and images were acquired at 4 h post-injection.
Signals in pancreas (Pa) increased proportionally to
dose, but background signal in surrounding organs,
including spleen (Sp) and duodenum (Du), rose significantly above the 25 nmol dose (Figure 2D). There
was no significant difference in SBR of (Pa/Sp) and
(Pa/Du) among 25 – 100 nmol groups (Figure 2C).

Intraoperative pancreas imaging and histology
in rats. We compared T700-F with MB in SD rats by
injecting 100 nmol of T700-F and 1.2 µmol (1.5 mg/kg)
of MB, respectively (Figure 3A). Although MB highlighted the pancreas immediately after a single intravenous injection, the fluorescent signal in pancreas
diminished rapidly after 15 min. Conversely, T700-F
showed strong pancreas signal and low background
uptake even at 4 h post-injection. After intraoperative
imaging, we resected the pancreas and performed
histological analysis (Figure 3B). NIR fluorescence
microscopy confirmed 700 nm fluorescence signal in
the resected pancreatic tissues. Both fluorophores
accumulated in the intracellular space: T700-F stained
both the exocrine pancreas (acini; AC) cells and islets
of Langerhans (IL), while MB exhibited proportionally higher islet uptake.
In vivo pancreas imaging in pigs. To confirm
that small animal results were not species-dependent,
we performed pancreas imaging in 35 kg Yorkshire
pigs using 164 µmol (1.5 mg/kg) of MB and 2.5 µmol
of T700-F. We administered more than a 65-fold
higher dose of MB, however, pancreatic contrast diminished rapidly over time while T700-F showed an
extremely strong pancreas signal (Figure 4A). Although the initial uptake of T700-F in spleen was
higher than in the pancreas, the fluorescence signal in
spleen decreased gradually and was negligible at 60
min post-injection. Adequate SBR (Pa/Mu) of MB was
only seen for the initial 15 min and the SBR decayed
by 60 min to almost the pre-injection level (Figure 4B).
In contrast, T700-F maintained its SBR (Pa/Mu) of ≈
5.0 for 60 min without detectable decrease and there
was a significant difference in SBR (Pa/Mu) for 1 h
between MB and T700-F. We further investigated the
kinetics of T700-F for up to 8 h by comparing signals
in the pancreas (Pa) with surrounding tissue and organs such as muscle (Mu), spleen (Sp), lymph nodes
(Ln), and kidneys (Ki) (Figure 4C). Overall T700-F
showed relatively high SBRs for up to 8 h without
significant decrease in the pancreatic signal except for
the SBR (Pa/Ki). Of note, no adverse reactions were
encountered over the 8 h observation period.

http://www.thno.org
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Figure 2. Quantitative Evaluation of NIR Fluorophore Uptake in Mouse Pancreas: a) SBR (mean ± SD) of pancreas against liver, spleen, and duodenum was compared using
various NIR fluorophores. b) Quantitative time-course assessment: 25 nmol of T700-F was injected intravenously into CD-1 mice, and SBR (Pa/Li), SBR (Pa/Sp) and SBR (Pa/Du)
were measured at different time points (T = 0, 1, 2, 4, 8, and 24 h). c) Dose-response curve: 0, 10, 25, 50 and 100 nmol of T700-F were injected intravenously into CD-1 mice,
and SBR (Pa/Li), SBR (Pa/Sp) and SBR (Pa/Du) were measured at 4 h post-injection. d) Real-time intraoperative imaging of pancreas in different time and doses. Controls were
injected with D5W alone, and at least 3 animals were used for each data point. Scale bars = 0.5 cm. *P < 0.05, **P < 0.01, and ***P < 0.001. Abbreviations used are: Du, duodenum;
Li, liver; Pa, pancreas (arrow); Sp, spleen; St, stomach; Pa/Li, pancreas-to-liver ratio; Pa/Sp, pancreas-to-spleen ratio; Pa/Du, pancreas-to-duodenum ratio. All NIR fluorescence
images have identical exposure times and normalizations.

http://www.thno.org
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Figure 3. Intraoperative Pancreas Imaging in SD Rats: a) 1.2 µmol of MB and 100 nmol of T700-F were injected intravenously 15 min and 4 h prior to imaging, respectively (n
= 3). Abbreviations used are: Bl, bladder; Du, duodenum; In, intestine; Ki, kidney; Li, liver; Pa, pancreas; Sp, spleen. Arrows indicate pancreas and arrowheads indicate autofluorescence of food in lumen of intestine. Scale bars = 1 cm. All NIR fluorescence images have identical exposure times and normalizations. b) Histological analysis: Consecutive
sections from rat pancreas stained with H&E or unstained were observed using an NIR fluorescence microscope. Abbreviations used are: Ac, acinus; IL, islets of Langerhans; PD,
pancreatic duct. Scale bars = 300 µm. All NIR fluorescence images for each condition have identical exposure times and normalizations.

http://www.thno.org
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Figure 4. Intraoperative Pancreas Imaging in Pigs: a) 164 µmol of MB and 2.5 µmol of T700-F were injected intravenously into 35 kg Yorkshire pigs, and images were recorded
over the course of 60 min (n = 3). Abbreviations used are: Du, duodenum; Ki, kidney; Li, liver; LN, lymph node; Pa, pancreas. All NIR fluorescence images have identical exposure
times and normalizations. b) SBR (mean ± SD) comparison between MB and T700-F: SBR (Pa/Mu) was measured at different time points. ***P < 0.001. Statistical analysis between
MB and T700-F was performed using unpaired t test. c) Quantitative time-course assessment of SBR (mean ± SD) for pancreas and surrounding organs/tissues were measured
after 2.5 µmol of T700-F injection over the course of 8 h (n = 3). Abbreviations used are: Pa/Mu, pancreas-to-muscle ratio; Pa/Sp, pancreas-to-spleen ratio; Pa/LN, pancreas-to-lymph node ratio; Pa/Ki, pancreas-to-kidney ratio. Scale bars = 1 cm. All NIR fluorescence images have identical exposure times and normalizations.

Simultaneous dual-channel imaging of pancreas for image-guided abdominal surgery. Since the
proximity of the pancreas to surrounding tissues and
organs, such as arteries, lymph nodes, kidneys, and
adrenal glands, is the main cause of intraoperative
pancreatic injury, we explored simultaneous dual-channel imaging of pancreas. With the assistance of
already developed 800 nm emitting NIR fluorophores
[13,15,21], the FLARE imaging system enabled 700 nm
and 800 nm NIR fluorescence imaging simultaneously
in real time.
To identify blood vessels, ZW800-1 was injected
intravenously into pig 4 h after injection of T700-F. As
shown in Figure 5, we could visualize not only im-

portant arteries in gastrointestinal surgery such as the
common hepatic artery, left gastric artery, and splenic
artery, but also extremely small vessel branches from
the common hepatic artery.
Because ZW800-1 is cleared from the body via
renal excretion, we continuously imaged kidneys and
found that kidney signal from ZW800-1 was highest
at 2 h post-injection [21]. As shown in Figure 5, this
permitted unambiguous identification of the boundary of pancreas from the kidney.
In subsequent experiments, we imaged peripancreatic lymph nodes by injecting ZW800-3C along
with T700-F 4 h prior to imaging [13]. Lymph nodes
were clearly visualized even when obscured by overhttp://www.thno.org
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lying pancreatic tissue, with the color merged image
showing all desired surgical landmarks on one screen.
Finally, for dual-channel imaging of pancreas
and adrenal glands, T700-F was injected 4 h prior to
imaging, followed by injecting ESNF31 intravenously
in the same pig 30 min prior to imaging [15]. Pancreas
and adrenal glands were readily imaged using the 700
nm and 800 nm NIR channels, respectively. This dual-channel imaging permitted the pancreas to be distinguished from peripancreatic lymph nodes and the
adrenal gland rather easily.

Discussion
Recent technical advances in abdominal surgery
have made complex procedures safer and shorter.
However, pancreas-related complications after gas-
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trectomy with radical lymphadenectomy including
peripancreatic lymph nodes resection, splenectomy,
adrenalectomy, and nephrectomy remain unacceptably high [1,2,9,10]. Even with a magnified view provided by laparoscopy, it remains difficult to avoid
pancreatic injury because of relatively poor contrast
between pancreas and surrounding tissues and organs, and the inability of visible light to penetrate
through blood and overlying tissue. NIR light has the
potential to solve this problem because it can penetrate 5-8 mm into living tissue [28] and specific NIR
contrast agents can be used to highlight specific
anatomy. Importantly, NIR fluorescence imaging
systems are now widely available for both open and
minimally-invasive surgery.

Figure 5. Simultaneous Dual Channel Imaging of Pancreas and Surrounding Tissues and Organs: 2.5 µmol of T700-F was injected intravenously for pancreas imaging 4 h prior to:
1st row: NIR angiography with 2 µmol intravenous injection of ZW800-1 immediately prior to imaging. 2nd row: Kidney imaging with 2 µmol intravenous injection of ZW800-1
30 min prior to imaging. 3rd row: Pan lymph node imaging with 1 µmol intravenous injection of ZW800-3C 4 h prior to imaging. 4th row: Adrenal gland imaging with 2 µmol
intravenous injection of ESNF31 30 min prior to imaging (n = 3 pigs). Shown are color image, 700 nm NIR fluorescence, 800 nm NIR fluorescence, and a merged image of the
three. For the merged image, FLARE™ channel #1 (700 nm) is pseudo-colored in red and channel #2 (800 nm) in green. Abbreviations used are: AG, adrenal gland; CHA,
common hepatic artery; Du, duodenum; In, intestine; Ki, kidney; Li, liver; LGA, left gastric artery; Pa, pancreas; Sp, spleen; St, stomach; SPA, splenic artery. Arrowheads indicate
tiny branch from artery (1st row), kidney (2nd row), pan lymph nodes (3rd row), or adrenal gland (4th row). Scale bars = 1 cm. All NIR fluorescence images have identical exposure
times and normalizations.

http://www.thno.org
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MB is a NIR fluorophore that we previously
demonstrated can highlight the pancreas, and interestingly, insulinoma, however, it has relatively poor
optical properties and short retention in the pancreas
[11]. Out of over 300 candidates, T700-F showed significantly high uptake in pancreas and low background tissue uptake. Furthermore, its retention in
pancreas was over 8 h, making this agent potentially
useful in complex abdominal surgeries including
laparoscopic operations (Figure 4C) [29]. Although
the mechanism of specific pancreas uptake and retention of T700-F is currently unknown, it appears that
the physicochemical properties of the substituted
pentamethine play a key role for targeting. T700-F
differs from T700-H by only 2 fluorine atoms, yet
these atoms result in significantly improved pancreas
selectivity.
There are some limitations, though, to the present study. First, our prototype pancreas-targeted
compound T700-F emits at 700 nm where autofluorescence exists from fecal contents. A thorough bowel
cleansing is therefore important. Development of an
800 nm version, which would solve this problem, is
ongoing. Second, T700-F shows nonspecific uptake in
kidneys, spleen, and lymph nodes and kidney, especially, has a higher signal than pancreas. However, as
shown in Figure 5, this limitation is easily overcome
by a low-dose injection of ZW800-1, which permits
unambiguous separation of kidney from pancreas.
Because first-in-human trials of ZW800-1 are imminent, it should be available for this application in the
near future. Third, T700-F will require the same regulatory path as any drug prior to human use. Despite
these limitations, this study lays the foundation for
real-time intraoperative pancreas imaging during
complex abdominal surgeries.

Supplementary Material
Fig.S1. http://www.thno.org/v05p0001s1.pdf
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standard deviation; AC: acini; IL: islets of Langerhans;

10
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